Chemed Corporation reiterates earnings guidance for full year 2024. For the full year, company reiterates earnings per diluted share, excluding: non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation, and other discrete items, guidance range of $23.30 to $23.70.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
571.1 USD | +1.68% | +0.80% | -2.34% |
Apr. 26 | Chemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer Says | MT |
Apr. 25 | Transcript : Chemed Corporation, Q1 2024 Earnings Call, Apr 25, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.34% | 8.61B | |
+14.55% | 81.21B | |
-29.12% | 70.26B | |
+11.76% | 29.62B | |
-11.55% | 16.95B | |
-1.43% | 16.91B | |
-1.62% | 15.07B | |
-1.90% | 12.52B | |
-31.75% | 11.92B | |
-5.39% | 12.1B |
- Stock Market
- Equities
- CHE Stock
- News Chemed Corporation
- Chemed Corporation Reiterates Earnings Guidance for Full Year 2024